﻿<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss xmlns:media="http://search.yahoo.com/mrss/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0">
  <channel>
    <atom:link href="http://www.genengnews.com/media/files/rss/DRUG-DISCOVERY-targets.xml" rel="self" type="application/rss+xml" />
    <title>Genetic Engineering &amp; Biotechnology News</title>
    <description>GEN has retained its position as the number one biotech publisher around the globe since its launch in 1981, with a print edition, additional content online, and a networking platform, GENconnect.</description>
    <lastBuildDate>Fri, 25 May 2012 19:53:31 -0400</lastBuildDate>
    <link>http://www.genengnews.com/media/files/rss/DRUG-DISCOVERY-targets.xml</link>
    <item>
      <title>Sihuan's First-to-market Generic Drug Roxatidine Passes On-site Inspection for Drug Registration Conducted by the Chinese State Food and Drug Administration</title>
      <link>http://www.genengnews.com/industry-updates/sihuan-s-first-to-market-generic-drug-roxatidine-passes-on-site-inspection-for-drug-registration/151919520/</link>
      <description></description>
      <guid>http://www.genengnews.com/industry-updates/sihuan-s-first-to-market-generic-drug-roxatidine-passes-on-site-inspection-for-drug-registration/151919520/</guid>
      <pubDate>Fri, 25 May 2012 08:00:00 -0400</pubDate>
      <media:thumbnail url="http://www.genengnews.com/media/images/newsletters/genlogo_red.gif" />
    </item>
  </channel>
</rss>
